Male hypogonadism. Part I: Epidemiology of hypogonadism. (Q30351499)

20 June 2017

1 reference

title

Male hypogonadism. Part I: Epidemiology of hypogonadism. (English)

1 reference

20 June 2017

1 reference

1 reference

Seftel AD

1

1 reference

20 June 2017

1 March 2006

1 reference

International Journal of Impotence Research

20 June 2017

1 reference

20 June 2017

18

1 reference

20 June 2017

2

1 reference

20 June 2017

115-120

1 reference

The challenge of health care delivery to the elderly patient with cardiovascular disease. Demographic, epidemiologic, fiscal, and health policy implications

20 June 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901397

Risks of testosterone-replacement therapy and recommendations for monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901397

Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901397

Sex hormone binding globulin: origin, function and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901397

Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901397

Endogenous sex hormones in men aged 40-80 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901397

Current estimates of the economic cost of obesity in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901397

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901397

NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901397

Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901397

Plasma free and non-sex-hormone-binding-globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901397

Depressed Plasma Testosterone and Fractional Binding of Testosterone in Obese Males*

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901397

Hypothalamic interleukin-1 beta and tumor necrosis factor-alpha, but not interleukin-6, mediate the endotoxin-induced suppression of the reproductive axis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901397

The in vitro role of tumour necrosis factor-alpha and interleukin-6 in the hypothalamic-pituitary gonadal axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901397

Testosterone as a protective factor against atherosclerosis--immunomodulation and influence upon plaque development and stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901397

Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901397

Value of gonadotropin-releasing hormone testing in the differential diagnosis of androgen deficiency in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901397

Risk factors in predicting a poor response to sildenafil citrate in elderly men with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901397

Summary of the recommendations on sexual dysfunctions in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901397

Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901397

Hypogonadism in elderly men--what to do until the evidence comes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901397

Plasma free testosterone--is an index sufficient?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901397

A mathematical comparison of techniques to predict biologically available testosterone in a cohort of 1072 men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901397

Effect of aging on serum gonadotropin levels in healthy subjects and patients with nonfunctioning pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901397

Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901397

inferred from DOI database lookup

7 January 2021

based on heuristic

Loss of circadian rhythmicity in blood testosterone levels with aging in normal men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901397

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.IJIR.3901397

1 reference

PubMed ID

16193071

Dimensions Publication ID

20 June 2017

0 references

1 reference

PubMed ID

16193071